{"id": "article-26933_0", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Continuing Education Activity", "content": "The liver is a common location for both primary and metastatic malignancies, which often result in significant morbidity and mortality. Traditional surgical resection provides excellent outcomes, but surgery is not an option for many patients due to extensive tumor burden, underlying hepatic disease, and other comorbidities. The evolution of image-guided technology has provided safe and effective alternatives for definitive and palliative treatment. This activity reviews the percutaneous radiofrequency ablation of liver tumors and highlights the role of the interprofessional team in managing patients who undergo this procedure.", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Continuing Education Activity. The liver is a common location for both primary and metastatic malignancies, which often result in significant morbidity and mortality. Traditional surgical resection provides excellent outcomes, but surgery is not an option for many patients due to extensive tumor burden, underlying hepatic disease, and other comorbidities. The evolution of image-guided technology has provided safe and effective alternatives for definitive and palliative treatment. This activity reviews the percutaneous radiofrequency ablation of liver tumors and highlights the role of the interprofessional team in managing patients who undergo this procedure."}
{"id": "article-26933_1", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Continuing Education Activity", "content": "Objectives: Outline the indications for percutaneous radiofrequency ablation in patients with liver tumors. Review the potential complications associated with percutaneous radiofrequency ablation of liver tumors. Describe the technique of percutaneous radiofrequency ablation. Explain the importance of improving care coordination among the interdisciplinary team to improve outcomes for patients undergoing percutaneous radiofrequency ablation of liver tumors. Access free multiple choice questions on this topic.", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Continuing Education Activity. Objectives: Outline the indications for percutaneous radiofrequency ablation in patients with liver tumors. Review the potential complications associated with percutaneous radiofrequency ablation of liver tumors. Describe the technique of percutaneous radiofrequency ablation. Explain the importance of improving care coordination among the interdisciplinary team to improve outcomes for patients undergoing percutaneous radiofrequency ablation of liver tumors. Access free multiple choice questions on this topic."}
{"id": "article-26933_2", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Introduction", "content": "The liver is a common location for both primary and\u00a0metastatic malignancies, which often result in significant morbidity and mortality. Traditional surgical\u00a0resection\u00a0provides excellent outcomes, but surgery is not an option for many patients due to\u00a0extensive tumor burden, underlying\u00a0hepatic disease, and other comorbidities. The evolution of\u00a0image-guided technology has provided safe and effective\u00a0alternatives\u00a0for definitive and palliative treatment. [1] One of the most frequently utilized non-surgical techniques for the treatment of hepatic malignancy is percutaneous radiofrequency ablation (RFA), the goal of\u00a0which is the complete destruction of a tumor via thermal injury\u00a0while preserving\u00a0adjacent healthy tissue. [2]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Introduction. The liver is a common location for both primary and\u00a0metastatic malignancies, which often result in significant morbidity and mortality. Traditional surgical\u00a0resection\u00a0provides excellent outcomes, but surgery is not an option for many patients due to\u00a0extensive tumor burden, underlying\u00a0hepatic disease, and other comorbidities. The evolution of\u00a0image-guided technology has provided safe and effective\u00a0alternatives\u00a0for definitive and palliative treatment. [1] One of the most frequently utilized non-surgical techniques for the treatment of hepatic malignancy is percutaneous radiofrequency ablation (RFA), the goal of\u00a0which is the complete destruction of a tumor via thermal injury\u00a0while preserving\u00a0adjacent healthy tissue. [2]"}
{"id": "article-26933_3", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Anatomy and Physiology", "content": "The liver has a dual blood supply.\u00a0The portal vein, which is responsible for splenic and intestinal drainage, provides approximately 80% of the blood supply to the liver. The portal vein forms by the union of the splenic vein and the superior mesenteric vein. The inferior mesenteric vein drains into the splenic vein. The hepatic artery supplies the remaining 20%. In most people, the proper hepatic artery branches from the common hepatic artery, which originates at the celiac axis. The proper hepatic artery subdivides into the right and left hepatic arteries, which\u00a0provide flow to the\u00a0right and left\u00a0hepatic lobes, respectively. However, multiple anatomic variations of the\u00a0right and\u00a0left hepatic arteries exist; these variants are known as \"accessory\" or \"replaced\" vessels.\u00a0The right hepatic artery is considered accessory or replaced when it originates\u00a0from the proximal aspect of the superior mesenteric artery, while the left gastric artery is often the origin of an accessory or replaced left hepatic artery. [3]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Anatomy and Physiology. The liver has a dual blood supply.\u00a0The portal vein, which is responsible for splenic and intestinal drainage, provides approximately 80% of the blood supply to the liver. The portal vein forms by the union of the splenic vein and the superior mesenteric vein. The inferior mesenteric vein drains into the splenic vein. The hepatic artery supplies the remaining 20%. In most people, the proper hepatic artery branches from the common hepatic artery, which originates at the celiac axis. The proper hepatic artery subdivides into the right and left hepatic arteries, which\u00a0provide flow to the\u00a0right and left\u00a0hepatic lobes, respectively. However, multiple anatomic variations of the\u00a0right and\u00a0left hepatic arteries exist; these variants are known as \"accessory\" or \"replaced\" vessels.\u00a0The right hepatic artery is considered accessory or replaced when it originates\u00a0from the proximal aspect of the superior mesenteric artery, while the left gastric artery is often the origin of an accessory or replaced left hepatic artery. [3]"}
{"id": "article-26933_4", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Anatomy and Physiology", "content": "Three hepatic veins allow for drainage of the liver. The liver is divided into anterior and posterior segments by the right hepatic vein. The left hepatic vein separates the liver into medial and lateral segments. The middle hepatic vein lies in the same plane as the inferior vena cava and the gallbladder fossa; it partitions the liver into the right and left lobes. The portal vein does not provide venous hepatic drainage, but it does divide the organ into the upper and lower hepatic segments. [3]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Anatomy and Physiology. Three hepatic veins allow for drainage of the liver. The liver is divided into anterior and posterior segments by the right hepatic vein. The left hepatic vein separates the liver into medial and lateral segments. The middle hepatic vein lies in the same plane as the inferior vena cava and the gallbladder fossa; it partitions the liver into the right and left lobes. The portal vein does not provide venous hepatic drainage, but it does divide the organ into the upper and lower hepatic segments. [3]"}
{"id": "article-26933_5", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Anatomy and Physiology", "content": "There\u00a0are multiple classification schemes for describing the various portions of the liver;\u00a0the Couinaud system is the most widely used. According to Couinaud, the liver is divided into eight independent functional sections.\u00a0Each section has its own portal pedicle comprised of\u00a0a branch of the right or left hepatic artery, a branch of the portal vein, a hepatic venous branch, and a bile duct. The sections\u00a0are numbered in a clockwise manner. The caudate lobe is segment I. Segment II\u00a0is the anterior segment of the left lobe, and segment III is the posterior segment of the left lobe. The medial segment of the left lobe is segment IV. Together, segments II, III, and IV represent\u00a0the left lobe of the liver. Conversely, the right lobe is comprised of segments V and VIII anteriorly and segments VI and VII\u00a0posteriorly. Classification of these various segments of liver anatomy is important to both radiologists and surgeons alike, especially\u00a0for preprocedural localization of focal hepatic lesions. [3]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Anatomy and Physiology. There\u00a0are multiple classification schemes for describing the various portions of the liver;\u00a0the Couinaud system is the most widely used. According to Couinaud, the liver is divided into eight independent functional sections.\u00a0Each section has its own portal pedicle comprised of\u00a0a branch of the right or left hepatic artery, a branch of the portal vein, a hepatic venous branch, and a bile duct. The sections\u00a0are numbered in a clockwise manner. The caudate lobe is segment I. Segment II\u00a0is the anterior segment of the left lobe, and segment III is the posterior segment of the left lobe. The medial segment of the left lobe is segment IV. Together, segments II, III, and IV represent\u00a0the left lobe of the liver. Conversely, the right lobe is comprised of segments V and VIII anteriorly and segments VI and VII\u00a0posteriorly. Classification of these various segments of liver anatomy is important to both radiologists and surgeons alike, especially\u00a0for preprocedural localization of focal hepatic lesions. [3]"}
{"id": "article-26933_6", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Indications", "content": "Hepatocellular carcinoma at a very early or early stage (\"very early\" stage includes patients with Child-Pugh A liver function and an Eastern Cooperative Oncology Group performance status of 0; early\" stage includes patients with Child-Pugh A-B liver function and an Eastern Cooperative Oncology Group performance status of 0). [4] [5] Liver metastases (traditionally, metastases from a colorectal primary\u00a0but now also indicated for metastases from breast, thyroid, and neuroendocrine primaries. [6] [7] [8] Hepatoma awaiting liver transplantation [9] The primary treatment for small tumors (a single tumor measuring 5 cm or less in diameter; 3 or fewer tumors, each measuring 3 cm or less in diameter) [10] [11] [12] Inoperable tumors (whether due to intrinsic characteristics of the lesion(s), the inability of the patient to tolerate general anesthesia or advanced age/comorbidity), recurrent tumors, or progressive tumors. [13] [14]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Indications. Hepatocellular carcinoma at a very early or early stage (\"very early\" stage includes patients with Child-Pugh A liver function and an Eastern Cooperative Oncology Group performance status of 0; early\" stage includes patients with Child-Pugh A-B liver function and an Eastern Cooperative Oncology Group performance status of 0). [4] [5] Liver metastases (traditionally, metastases from a colorectal primary\u00a0but now also indicated for metastases from breast, thyroid, and neuroendocrine primaries. [6] [7] [8] Hepatoma awaiting liver transplantation [9] The primary treatment for small tumors (a single tumor measuring 5 cm or less in diameter; 3 or fewer tumors, each measuring 3 cm or less in diameter) [10] [11] [12] Inoperable tumors (whether due to intrinsic characteristics of the lesion(s), the inability of the patient to tolerate general anesthesia or advanced age/comorbidity), recurrent tumors, or progressive tumors. [13] [14]"}
{"id": "article-26933_7", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Absolute Contraindications", "content": "Surgically resectable\u00a0tumors\u00a0and/or favorable transplantation status (if\u00a0the tumors\u00a0are deemed operable and/or the patient is a good candidate for transplantation, these methods of treatments should be pursued as they currently provide the best outcomes) [1] Vascular invasion by the tumor(s) [15] Tumor location of less than 1 cm from the main biliary duct (at this distance, bile ducts\u00a0are at risk of injury\u00a0when not protected simultaneously with intraductal cooling. Abscess formation, biliary stenosis, and biliary obstruction occur more frequently when bile ducts are within the area of thermally induced necrosis) [15] Intrahepatic biliary tree dilatation [15] Exophytic tumor location (due to the risk of tumor seeding) [15] Uncorrectable coagulopathy [15]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Absolute Contraindications. Surgically resectable\u00a0tumors\u00a0and/or favorable transplantation status (if\u00a0the tumors\u00a0are deemed operable and/or the patient is a good candidate for transplantation, these methods of treatments should be pursued as they currently provide the best outcomes) [1] Vascular invasion by the tumor(s) [15] Tumor location of less than 1 cm from the main biliary duct (at this distance, bile ducts\u00a0are at risk of injury\u00a0when not protected simultaneously with intraductal cooling. Abscess formation, biliary stenosis, and biliary obstruction occur more frequently when bile ducts are within the area of thermally induced necrosis) [15] Intrahepatic biliary tree dilatation [15] Exophytic tumor location (due to the risk of tumor seeding) [15] Uncorrectable coagulopathy [15]"}
{"id": "article-26933_8", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "Extrahepatic\u00a0metastases (treatment of\u00a0liver tumors may be attempted if successful treatment of extrahepatic metastasis is felt to be achievable) [16]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. Extrahepatic\u00a0metastases (treatment of\u00a0liver tumors may be attempted if successful treatment of extrahepatic metastasis is felt to be achievable) [16]"}
{"id": "article-26933_9", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "Bilioenteric anastomosis (due to potential infection; antibiotic prophylaxis may aid in prevention) [17]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. Bilioenteric anastomosis (due to potential infection; antibiotic prophylaxis may aid in prevention) [17]"}
{"id": "article-26933_10", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "Superficial/subcapsular lesions, especially adjacent to any portion of the gastrointestinal tract or gallbladder (risk of thermal injury of the gastric/bowel wall or iatrogenic cholecystitis; open approach preferred) [18]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. Superficial/subcapsular lesions, especially adjacent to any portion of the gastrointestinal tract or gallbladder (risk of thermal injury of the gastric/bowel wall or iatrogenic cholecystitis; open approach preferred) [18]"}
{"id": "article-26933_11", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "Child-Pugh class C cirrhosis or decompensated liver disease [4] [5]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. Child-Pugh class C cirrhosis or decompensated liver disease [4] [5]"}
{"id": "article-26933_12", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "Tumors difficult to reach\u00a0with electrodes or when electrode placement is impaired (In these cases, an open approach is preferred) [19] [20]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. Tumors difficult to reach\u00a0with electrodes or when electrode placement is impaired (In these cases, an open approach is preferred) [19] [20]"}
{"id": "article-26933_13", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "Single tumor greater than 5 cm in diameter or multiple lesions each greater than 3 cm in diameter (RFA may be utilized in larger hepatic tumors with the purpose of debulking the lesion prior to chemotherapy or for pain relief as opposed to definitive treatment) [10] [11] [12]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. Single tumor greater than 5 cm in diameter or multiple lesions each greater than 3 cm in diameter (RFA may be utilized in larger hepatic tumors with the purpose of debulking the lesion prior to chemotherapy or for pain relief as opposed to definitive treatment) [10] [11] [12]"}
{"id": "article-26933_14", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "More than 3 tumors (treatment of more lesions may be attempted\u00a0if successful treatment is felt to be achievable) [10] [11] [12]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. More than 3 tumors (treatment of more lesions may be attempted\u00a0if successful treatment is felt to be achievable) [10] [11] [12]"}
{"id": "article-26933_15", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications", "content": "Tumors immediately adjacent to hepatic vasculature (flowing blood usually protects the vascular wall from thermal injury\u00a0but decreases procedure efficacy due to heat loss by convection) [18]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Contraindications -- Relative Contraindications. Tumors immediately adjacent to hepatic vasculature (flowing blood usually protects the vascular wall from thermal injury\u00a0but decreases procedure efficacy due to heat loss by convection) [18]"}
{"id": "article-26933_16", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Equipment", "content": "RFA is an ablation technique that creates areas of\u00a0tissue necrosis\u00a0by applying heat to cancerous tissues. To create the zone of ablation, alternating current is applied to the tumor via\u00a0an electrode. To create a closed electrical circuit, the electrode\u00a0operates as a cathode, while multiple grounding pads attached to the skin behave as an anode. Ions in close proximity to the electrode\u00a0reverberate\u00a0quickly\u00a0while attempting to line up with the alternating current. This results in elevated temperatures within\u00a0both the tumor (direct heating) as well as the surrounding tissues (indirect heating) - the combination of these effects comprise the final zone of ablation. [21] [22] RFA requires 3\u00a0main pieces of equipment: [23] A\u00a0probe (electrode needle with deployable ablative tynes and thermocouples) An electrical generator Multiple grounding pads", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Equipment. RFA is an ablation technique that creates areas of\u00a0tissue necrosis\u00a0by applying heat to cancerous tissues. To create the zone of ablation, alternating current is applied to the tumor via\u00a0an electrode. To create a closed electrical circuit, the electrode\u00a0operates as a cathode, while multiple grounding pads attached to the skin behave as an anode. Ions in close proximity to the electrode\u00a0reverberate\u00a0quickly\u00a0while attempting to line up with the alternating current. This results in elevated temperatures within\u00a0both the tumor (direct heating) as well as the surrounding tissues (indirect heating) - the combination of these effects comprise the final zone of ablation. [21] [22] RFA requires 3\u00a0main pieces of equipment: [23] A\u00a0probe (electrode needle with deployable ablative tynes and thermocouples) An electrical generator Multiple grounding pads"}
{"id": "article-26933_17", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Equipment", "content": "There are two forms of needle electrodes. A straight, solid needle is the first type.\u00a0The second type is more\u00a0complex\u00a0- the needle\u00a0is straight but hollow, containing multiple curved tynes that are retracted\u00a0until the needle tip is\u00a0placed\u00a0inside a lesion. Incorporated into the tips of the tynes are thermocouples which act as tiny thermometers, allowing for continuous temperature monitoring throughout the procedure. Once appropriately situated in the tumor, the electrode tynes are advanced. The extended tynes resemble the spokes of an open umbrella. [23]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Equipment. There are two forms of needle electrodes. A straight, solid needle is the first type.\u00a0The second type is more\u00a0complex\u00a0- the needle\u00a0is straight but hollow, containing multiple curved tynes that are retracted\u00a0until the needle tip is\u00a0placed\u00a0inside a lesion. Incorporated into the tips of the tynes are thermocouples which act as tiny thermometers, allowing for continuous temperature monitoring throughout the procedure. Once appropriately situated in the tumor, the electrode tynes are advanced. The extended tynes resemble the spokes of an open umbrella. [23]"}
{"id": "article-26933_18", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Equipment", "content": "The\u00a0RF generator is\u00a0coupled to the electrode through insulated wires as well as multiple grounding pads, which are positioned on the skin of the thighs of the patient. The electrical generator\u00a0creates an alternating current of approximately 300-500kHz (the RF range). [23]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Equipment. The\u00a0RF generator is\u00a0coupled to the electrode through insulated wires as well as multiple grounding pads, which are positioned on the skin of the thighs of the patient. The electrical generator\u00a0creates an alternating current of approximately 300-500kHz (the RF range). [23]"}
{"id": "article-26933_19", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Preprocedural Imaging, Laboratory Analysis, and Consent", "content": "Patients\u00a0should only be deemed\u00a0appropriate candidates following the evaluation of their specific case either via multidisciplinary tumor board or in\u00a0conjunction with\u00a0surgical and\u00a0oncology services, as resection still represents the best curative option for good surgical\u00a0candidates with\u00a0appropriate hepatic reserve. Patients\u00a0that are deemed appropriate\u00a0for RF\u00a0require\u00a0an imaging workup prior to the procedure. This typically includes a contrast-enhanced computed tomography (CT) and/or gadolinium-enhanced magnetic resonance imaging (MRI) for both tumor staging and planning of RFA needle trajectory. [24]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Preprocedural Imaging, Laboratory Analysis, and Consent. Patients\u00a0should only be deemed\u00a0appropriate candidates following the evaluation of their specific case either via multidisciplinary tumor board or in\u00a0conjunction with\u00a0surgical and\u00a0oncology services, as resection still represents the best curative option for good surgical\u00a0candidates with\u00a0appropriate hepatic reserve. Patients\u00a0that are deemed appropriate\u00a0for RF\u00a0require\u00a0an imaging workup prior to the procedure. This typically includes a contrast-enhanced computed tomography (CT) and/or gadolinium-enhanced magnetic resonance imaging (MRI) for both tumor staging and planning of RFA needle trajectory. [24]"}
{"id": "article-26933_20", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Preprocedural Imaging, Laboratory Analysis, and Consent", "content": "Laboratory evaluation is performed on\u00a0all patients.\u00a0Tests typically include coagulation studies,\u00a0liver function studies, and tumor marker levels. A histological tissue sample\u00a0confirming the diagnosis (or pathognomonic image findings with high levels of concordant tumor markers) is required for patients with hepatocellular carcinoma. [24]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Preprocedural Imaging, Laboratory Analysis, and Consent. Laboratory evaluation is performed on\u00a0all patients.\u00a0Tests typically include coagulation studies,\u00a0liver function studies, and tumor marker levels. A histological tissue sample\u00a0confirming the diagnosis (or pathognomonic image findings with high levels of concordant tumor markers) is required for patients with hepatocellular carcinoma. [24]"}
{"id": "article-26933_21", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Preprocedural Imaging, Laboratory Analysis, and Consent", "content": "Finally, patients deemed candidates for percutaneous hepatic RFA must meet with the physician, typically an interventional radiologist, who will be performing the procedure to discuss\u00a0risks, benefits, and alternatives to the procedure. Patient questions are answered at that time. [24]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Preprocedural Imaging, Laboratory Analysis, and Consent. Finally, patients deemed candidates for percutaneous hepatic RFA must meet with the physician, typically an interventional radiologist, who will be performing the procedure to discuss\u00a0risks, benefits, and alternatives to the procedure. Patient questions are answered at that time. [24]"}
{"id": "article-26933_22", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Anesthesia", "content": "Percutaneous RFA\u00a0is typically\u00a0performed under general anesthesia, although the use of local anesthesia and mild/deep sedation have\u00a0been described in the literature. The type of anesthesia will play a role in determining if the procedure is performed as an outpatient, same day, or overnight stay.\u00a0General anesthesia is usually preferred by most interventionalists as it allows patients to better tolerate any discomfort associated with the procedure.\u00a0Interestingly, at least one study demonstrated a reduction in tumor recurrence in patients who underwent percutaneous RFA for small hepatocellular carcinomas under general anesthesia. [25]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Anesthesia. Percutaneous RFA\u00a0is typically\u00a0performed under general anesthesia, although the use of local anesthesia and mild/deep sedation have\u00a0been described in the literature. The type of anesthesia will play a role in determining if the procedure is performed as an outpatient, same day, or overnight stay.\u00a0General anesthesia is usually preferred by most interventionalists as it allows patients to better tolerate any discomfort associated with the procedure.\u00a0Interestingly, at least one study demonstrated a reduction in tumor recurrence in patients who underwent percutaneous RFA for small hepatocellular carcinomas under general anesthesia. [25]"}
{"id": "article-26933_23", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Positioning", "content": "Positioning depends entirely on the imaging modality utilized for the procedure, the location of the tumor(s), the\u00a0type of anesthesia, and physician/patient preferences. The goal is to avoid compromising the ability of the interventionalist to see and treat the tumor satisfactorily. [24]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Preparation -- Positioning. Positioning depends entirely on the imaging modality utilized for the procedure, the location of the tumor(s), the\u00a0type of anesthesia, and physician/patient preferences. The goal is to avoid compromising the ability of the interventionalist to see and treat the tumor satisfactorily. [24]"}
{"id": "article-26933_24", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure", "content": "Percutaneous RFA is performed by an interventional radiologist in the radiology suite after\u00a0anesthesia/sedation. [18]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure. Percutaneous RFA is performed by an interventional radiologist in the radiology suite after\u00a0anesthesia/sedation. [18]"}
{"id": "article-26933_25", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure", "content": "Before\u00a0a needle is inserted into a lesion, the point of entry, a safe trajectory, and the end position of the needle are planned\u00a0via a review of pre-procedural\u00a0imaging. Once a window of access is determined, the\u00a0probe is introduced to the tumor\u00a0percutaneously, typically under sonographic or computed tomographic (CT) guidance.\u00a0Then, if required, a local anesthetic may be\u00a0administered along the tract.\u00a0Subsequently, the electrode\u00a0is\u00a0advanced\u00a0through the anesthetized track and into the mass. [18]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure. Before\u00a0a needle is inserted into a lesion, the point of entry, a safe trajectory, and the end position of the needle are planned\u00a0via a review of pre-procedural\u00a0imaging. Once a window of access is determined, the\u00a0probe is introduced to the tumor\u00a0percutaneously, typically under sonographic or computed tomographic (CT) guidance.\u00a0Then, if required, a local anesthetic may be\u00a0administered along the tract.\u00a0Subsequently, the electrode\u00a0is\u00a0advanced\u00a0through the anesthetized track and into the mass. [18]"}
{"id": "article-26933_26", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure", "content": "RFA\u00a0is performed in the same manner\u00a0despite the probe type; the only variations are\u00a0the amount of power utilized and the length of ablative time. For lesions equal to or less than 2 cm in diameter, a needle electrode\u00a0is positioned\u00a0centrally within the tumor.\u00a0The electrode tynes\u00a0are\u00a0extended\u00a0to deliver 50 to 200 watts of alternating current. Once the temperature reaches\u00a090\u00b0C,\u00a0ablation is performed for approximately 8 to 25 minutes. The duration of ablation depends on the type of probe utilized.\u00a0Both the tumor and a 1 cm surrounding margin of\u00a0normal tissue are ablated. A tyne temperature\u00a0of at least 60\u00b0C, approximately 30 seconds after the ablation ends, is necessary to ensure\u00a0satisfactory\u00a0tumor\u00a0necrosis. [18]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure. RFA\u00a0is performed in the same manner\u00a0despite the probe type; the only variations are\u00a0the amount of power utilized and the length of ablative time. For lesions equal to or less than 2 cm in diameter, a needle electrode\u00a0is positioned\u00a0centrally within the tumor.\u00a0The electrode tynes\u00a0are\u00a0extended\u00a0to deliver 50 to 200 watts of alternating current. Once the temperature reaches\u00a090\u00b0C,\u00a0ablation is performed for approximately 8 to 25 minutes. The duration of ablation depends on the type of probe utilized.\u00a0Both the tumor and a 1 cm surrounding margin of\u00a0normal tissue are ablated. A tyne temperature\u00a0of at least 60\u00b0C, approximately 30 seconds after the ablation ends, is necessary to ensure\u00a0satisfactory\u00a0tumor\u00a0necrosis. [18]"}
{"id": "article-26933_27", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure", "content": "Large tumors\u00a0require\u00a0multiple overlapping ablation fields. Instead of placing the probe at the center of the lesion as is done with smaller lesions, the\u00a0electrode is positioned along the distal edge of the tumor.\u00a0Several\u00a0superimposed ablations are performed sequentially,\u00a0moving proximally\u00a0until the entire lesion and a 1 cm\u00a0margin of normal\u00a0tissue have been\u00a0adequately ablated. Successful RFA\u00a0requires sustained progressive heat. This ensures that the\u00a0temperature required to\u00a0cause coagulative necrosis is reached without creating \"charring\" (carbonization), which can hinder\u00a0electrical flow and, thus, tissue ablation. [18]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure. Large tumors\u00a0require\u00a0multiple overlapping ablation fields. Instead of placing the probe at the center of the lesion as is done with smaller lesions, the\u00a0electrode is positioned along the distal edge of the tumor.\u00a0Several\u00a0superimposed ablations are performed sequentially,\u00a0moving proximally\u00a0until the entire lesion and a 1 cm\u00a0margin of normal\u00a0tissue have been\u00a0adequately ablated. Successful RFA\u00a0requires sustained progressive heat. This ensures that the\u00a0temperature required to\u00a0cause coagulative necrosis is reached without creating \"charring\" (carbonization), which can hinder\u00a0electrical flow and, thus, tissue ablation. [18]"}
{"id": "article-26933_28", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure", "content": "After the\u00a0ablation, the electrode\u00a0is withdrawn while cauterizing the entry tract\u00a0in an effort to prevent seeding of the pathway by tumor cells. For\u00a0tumors located near vasculature, heat may be dissipated by cooler blood flowing through these vessels - an effect known as \"heat sink.\" To attain effective temperatures in these cases, the tynes must be rotated or withdrawn slightly. [18] Postoperatively, patients undergo immediate repeat imaging (typically with contrast-enhanced CT) to evaluate the ablation(s) and look for potential complications. [18]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Procedure. After the\u00a0ablation, the electrode\u00a0is withdrawn while cauterizing the entry tract\u00a0in an effort to prevent seeding of the pathway by tumor cells. For\u00a0tumors located near vasculature, heat may be dissipated by cooler blood flowing through these vessels - an effect known as \"heat sink.\" To attain effective temperatures in these cases, the tynes must be rotated or withdrawn slightly. [18] Postoperatively, patients undergo immediate repeat imaging (typically with contrast-enhanced CT) to evaluate the ablation(s) and look for potential complications. [18]"}
{"id": "article-26933_29", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Post-Procedural Assessment and Follow-Up", "content": "RFA is typically performed in specialty centers. This allows for evaluation by radiologists familiar with the post-RFA\u00a0image appearance of treated (and recurrent) tumors. Post-RFA assessment often involves\u00a0CT, ultrasound, MRI, and/or PET imaging. Studies are typically performed 4 to 6 weeks following the ablation.\u00a0Later follow-up imaging studies may occur on a variable schedule but should be aimed at detecting local tumor recurrence, development of new lesions, or the emergence of extrahepatic disease. [15]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Post-Procedural Assessment and Follow-Up. RFA is typically performed in specialty centers. This allows for evaluation by radiologists familiar with the post-RFA\u00a0image appearance of treated (and recurrent) tumors. Post-RFA assessment often involves\u00a0CT, ultrasound, MRI, and/or PET imaging. Studies are typically performed 4 to 6 weeks following the ablation.\u00a0Later follow-up imaging studies may occur on a variable schedule but should be aimed at detecting local tumor recurrence, development of new lesions, or the emergence of extrahepatic disease. [15]"}
{"id": "article-26933_30", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT", "content": "Perihepatic\u00a0fluid, right lung base pulmonary consolidation, and right-sided\u00a0pleural effusion are normal, commonly\u00a0seen changes on immediate post-RFA imaging. Free fluid in the peritoneal cavity can also be seen, which\u00a0typically resolves in days. [7] Iatrogenic arterioportal shunting and small\u00a0peri-tumoral\u00a0foci of air as well as RFA-induced arterioportal vascular shunting\u00a0are also frequently\u00a0seen on immediate\u00a0post-procedural\u00a0CT and\u00a0frequently\u00a0resolve within one month. [26]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT. Perihepatic\u00a0fluid, right lung base pulmonary consolidation, and right-sided\u00a0pleural effusion are normal, commonly\u00a0seen changes on immediate post-RFA imaging. Free fluid in the peritoneal cavity can also be seen, which\u00a0typically resolves in days. [7] Iatrogenic arterioportal shunting and small\u00a0peri-tumoral\u00a0foci of air as well as RFA-induced arterioportal vascular shunting\u00a0are also frequently\u00a0seen on immediate\u00a0post-procedural\u00a0CT and\u00a0frequently\u00a0resolve within one month. [26]"}
{"id": "article-26933_31", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT", "content": "A smooth, uniform, symmetric, concentric rim of enhancement surrounding\u00a0the ablation zone, which represents a benign physiologic response to thermal injury, is the most common imaging\u00a0feature in the\u00a0first month. [27] Nearly 90% of patients will have this finding. [28]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT. A smooth, uniform, symmetric, concentric rim of enhancement surrounding\u00a0the ablation zone, which represents a benign physiologic response to thermal injury, is the most common imaging\u00a0feature in the\u00a0first month. [27] Nearly 90% of patients will have this finding. [28]"}
{"id": "article-26933_32", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT", "content": "A low-density\u00a0lesion with\u00a0no contrast enhancement approximately 1 to 3 months following the procedure represents a successful ablation. [27] The shape of the lesion\u00a0is not considered a significant parameter\u00a0to differentiate between treatment success or failure. [29] Conversely, thick, nodular, eccentric rim enhancement\u00a0and/or an increase in the size of the treated lesion are\u00a0reliable indicators of\u00a0tumor recurrence and, thus, treatment failure. [30] Four different contrast-enhanced CT recurrence patterns following RFA\u00a0have been described in the literature: [31]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT. A low-density\u00a0lesion with\u00a0no contrast enhancement approximately 1 to 3 months following the procedure represents a successful ablation. [27] The shape of the lesion\u00a0is not considered a significant parameter\u00a0to differentiate between treatment success or failure. [29] Conversely, thick, nodular, eccentric rim enhancement\u00a0and/or an increase in the size of the treated lesion are\u00a0reliable indicators of\u00a0tumor recurrence and, thus, treatment failure. [30] Four different contrast-enhanced CT recurrence patterns following RFA\u00a0have been described in the literature: [31]"}
{"id": "article-26933_33", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT", "content": "Ingrowth: Enhancing tissue\u00a0inside the\u00a0border of the treated lesion, denoting\u00a0inward growth\u00a0of the tumor. Outgrowth: Enhancing tissue expanding outward from (but contiguous with) the border of the\u00a0treated lesion, denoting outward growth of the tumor. Spread: New enhancing tissue separate from the treated lesion but contained within the same Couinaud\u00a0liver segment Progression: New enhancing tissue\u00a0seen in different Couinaud liver segments from the treated lesion", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT. Ingrowth: Enhancing tissue\u00a0inside the\u00a0border of the treated lesion, denoting\u00a0inward growth\u00a0of the tumor. Outgrowth: Enhancing tissue expanding outward from (but contiguous with) the border of the\u00a0treated lesion, denoting outward growth of the tumor. Spread: New enhancing tissue separate from the treated lesion but contained within the same Couinaud\u00a0liver segment Progression: New enhancing tissue\u00a0seen in different Couinaud liver segments from the treated lesion"}
{"id": "article-26933_34", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT", "content": "The post-ablation zone of necrosis should be\u00a0larger in size than the actual lesion due to the additional 1 cm margin of normal hepatic parenchyma included in the ablation. If an ablation zone is noted to incompletely encompass the original lesion, close follow up is advised as viable tumor cells may still be present. [26] The ablation zone may remain the same size or gradually decrease over time. Calcification\u00a0may or may not develop along\u00a0the edge of the ablation zone. [7]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Contrast-enhanced CT. The post-ablation zone of necrosis should be\u00a0larger in size than the actual lesion due to the additional 1 cm margin of normal hepatic parenchyma included in the ablation. If an ablation zone is noted to incompletely encompass the original lesion, close follow up is advised as viable tumor cells may still be present. [26] The ablation zone may remain the same size or gradually decrease over time. Calcification\u00a0may or may not develop along\u00a0the edge of the ablation zone. [7]"}
{"id": "article-26933_35", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Ultrasonography", "content": "Grayscale", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Ultrasonography. Grayscale"}
{"id": "article-26933_36", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Ultrasonography", "content": "Sonographic exam following RFA will be variable. A simple grayscale\u00a0sonographic exam in and of itself\u00a0is not a\u00a0sensitive imaging modality for follow-up due to limited ability to differentiate between an area of RFA-induced necrosis and residual tumor.\u00a0Ultrasound findings post RFA are variable and may show echo-poor, echogenic, or mixed appearance. [26] Contrast-enhanced", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Ultrasonography. Sonographic exam following RFA will be variable. A simple grayscale\u00a0sonographic exam in and of itself\u00a0is not a\u00a0sensitive imaging modality for follow-up due to limited ability to differentiate between an area of RFA-induced necrosis and residual tumor.\u00a0Ultrasound findings post RFA are variable and may show echo-poor, echogenic, or mixed appearance. [26] Contrast-enhanced"}
{"id": "article-26933_37", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Ultrasonography", "content": "While not readily available at all institutions, contrast-enhanced sonography represents a rapid and cost-effective alternative to traditional CT and MRI post-RFA follow-up imaging studies.\u00a0Additionally, ultrasound examination inherently lacks the radiation exposure of the aforementioned traditional follow-up modalities. [32] Interestingly, multiple sources report that\u00a0RFA-induced changes, such as necrosis, often\u00a0appear smaller when imaged with contrast-enhanced ultrasound versus contrast-enhanced CT. [33] Limitations of contrast-enhanced ultrasound include\u00a0limited ability to visualize the safety margin (the additional 1cm of ablated normal parenchyma surrounding the tumor). [7]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Ultrasonography. While not readily available at all institutions, contrast-enhanced sonography represents a rapid and cost-effective alternative to traditional CT and MRI post-RFA follow-up imaging studies.\u00a0Additionally, ultrasound examination inherently lacks the radiation exposure of the aforementioned traditional follow-up modalities. [32] Interestingly, multiple sources report that\u00a0RFA-induced changes, such as necrosis, often\u00a0appear smaller when imaged with contrast-enhanced ultrasound versus contrast-enhanced CT. [33] Limitations of contrast-enhanced ultrasound include\u00a0limited ability to visualize the safety margin (the additional 1cm of ablated normal parenchyma surrounding the tumor). [7]"}
{"id": "article-26933_38", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Magnetic Resonance Imaging", "content": "MRI with or without gadolinium may be useful for assessing outcomes after RFA. A contrast-enhanced study will\u00a0inherently\u00a0be more useful than a plain, unenhanced one due to improved visualization of the ablation zone. [34] On MRI, ablation should be considered a success if there is\u00a0no residual tumoral enhancement as well as low signal intensity on T2-weighted images. [35] While more time consuming than CT, MRI is more sensitive than\u00a0CT at detecting tumor regrowth.\u00a0Local tumor recurrence\u00a0is often seen on T2-weighted images\u00a0earlier than on contrast-enhanced CT. [33]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Technique or Treatment -- Magnetic Resonance Imaging. MRI with or without gadolinium may be useful for assessing outcomes after RFA. A contrast-enhanced study will\u00a0inherently\u00a0be more useful than a plain, unenhanced one due to improved visualization of the ablation zone. [34] On MRI, ablation should be considered a success if there is\u00a0no residual tumoral enhancement as well as low signal intensity on T2-weighted images. [35] While more time consuming than CT, MRI is more sensitive than\u00a0CT at detecting tumor regrowth.\u00a0Local tumor recurrence\u00a0is often seen on T2-weighted images\u00a0earlier than on contrast-enhanced CT. [33]"}
{"id": "article-26933_39", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Post-ablation Syndrome", "content": "Post ablation syndrome is a common, self-limiting phenomenon observed in\u00a0nearly one-third of patients following\u00a0RFA. The symptoms are flu-like, last approximately seven to ten days following the procedure, and include the following: [36] Low-grade fever Delayed pain Malaise Myalgia Nausea Vomiting", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Post-ablation Syndrome. Post ablation syndrome is a common, self-limiting phenomenon observed in\u00a0nearly one-third of patients following\u00a0RFA. The symptoms are flu-like, last approximately seven to ten days following the procedure, and include the following: [36] Low-grade fever Delayed pain Malaise Myalgia Nausea Vomiting"}
{"id": "article-26933_40", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage", "content": "Hemorrhage, both intra-abdominal and intra-hepatic,\u00a0is the most\u00a0frequent post-RFA complication\u00a0seen,, according to numerous studies.\u00a0Bleeding typically occurs due to\u00a0direct trauma from improper positioning of the electrode with resultant injury to small vessels as opposed to\u00a0direct heat-related injury. It may be venous or arterial in nature and commonly presents as increasing abdominal pain after RFA.\u00a0Imaging such as CT or ultrasound\u00a0is confirmatory. Hemorrhagic complications\u00a0occur more often\u00a0in patients with hepatocellular carcinoma due to coagulation issues related to underlying cirrhosis. This complication can be preempted by avoiding\u00a0hepatic vessels during the positioning of the electrode whenever possible, highlighting\u00a0the\u00a0essential role of\u00a0effective imaging guidance. Venous\u00a0hemorrhage usually ceases spontaneously without additional intervention\u00a0and/or\u00a0blood transfusions only; arterial bleeding\u00a0may be more severe, requiring endovascular or, more rarely, surgical intervention. Cauterization of the needle tract on the removal of the electrode probe\u00a0should always be performed to help reduce this complication. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage. Hemorrhage, both intra-abdominal and intra-hepatic,\u00a0is the most\u00a0frequent post-RFA complication\u00a0seen,, according to numerous studies.\u00a0Bleeding typically occurs due to\u00a0direct trauma from improper positioning of the electrode with resultant injury to small vessels as opposed to\u00a0direct heat-related injury. It may be venous or arterial in nature and commonly presents as increasing abdominal pain after RFA.\u00a0Imaging such as CT or ultrasound\u00a0is confirmatory. Hemorrhagic complications\u00a0occur more often\u00a0in patients with hepatocellular carcinoma due to coagulation issues related to underlying cirrhosis. This complication can be preempted by avoiding\u00a0hepatic vessels during the positioning of the electrode whenever possible, highlighting\u00a0the\u00a0essential role of\u00a0effective imaging guidance. Venous\u00a0hemorrhage usually ceases spontaneously without additional intervention\u00a0and/or\u00a0blood transfusions only; arterial bleeding\u00a0may be more severe, requiring endovascular or, more rarely, surgical intervention. Cauterization of the needle tract on the removal of the electrode probe\u00a0should always be performed to help reduce this complication. [37]"}
{"id": "article-26933_41", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage", "content": "Hemothorax\u00a0may also occur but\u00a0less frequently than\u00a0abdominal hemorrhage.\u00a0Thoracic hemorrhage\u00a0usually results\u00a0from\u00a0arterial injury while\u00a0performing RFA for\u00a0lesions in the right hepatic lobe\u00a0utilizing\u00a0an intercostal approach. The most common symptoms are shortness of breath\u00a0and chest pain. Ultrasound, CT of the chest, and/or chest X-ray are\u00a0confirmatory. Invention to aid in the cessation of hemorrhage, as well as drainage,\u00a0are typically necessary. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage. Hemothorax\u00a0may also occur but\u00a0less frequently than\u00a0abdominal hemorrhage.\u00a0Thoracic hemorrhage\u00a0usually results\u00a0from\u00a0arterial injury while\u00a0performing RFA for\u00a0lesions in the right hepatic lobe\u00a0utilizing\u00a0an intercostal approach. The most common symptoms are shortness of breath\u00a0and chest pain. Ultrasound, CT of the chest, and/or chest X-ray are\u00a0confirmatory. Invention to aid in the cessation of hemorrhage, as well as drainage,\u00a0are typically necessary. [37]"}
{"id": "article-26933_42", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage", "content": "Hemobilia, bleeding within the bile ducts, is another type of RFA-related hemorrhage. It\u00a0occurs when both\u00a0a bile duct and a hepatic artery/vein are simultaneously punctured. Abdominal pain is the most common symptom, albeit nonspecific. The\u00a0biggest issue with hemobilia is the resultant\u00a0obstruction of the biliary tree\u00a0with\u00a0thrombus, which can result in biliary dysfunction and, thus, jaundice and\u00a0hepatic failure. Tumors in the caudate lobe (Couinaud segment I) pose the highest risk for this complication. Avoidance of dilated biliary radicles during the placement of the electrode probe should aid in prevention. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage. Hemobilia, bleeding within the bile ducts, is another type of RFA-related hemorrhage. It\u00a0occurs when both\u00a0a bile duct and a hepatic artery/vein are simultaneously punctured. Abdominal pain is the most common symptom, albeit nonspecific. The\u00a0biggest issue with hemobilia is the resultant\u00a0obstruction of the biliary tree\u00a0with\u00a0thrombus, which can result in biliary dysfunction and, thus, jaundice and\u00a0hepatic failure. Tumors in the caudate lobe (Couinaud segment I) pose the highest risk for this complication. Avoidance of dilated biliary radicles during the placement of the electrode probe should aid in prevention. [37]"}
{"id": "article-26933_43", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage", "content": "Bleeding within the liver capsule, known as a subcapsular hematoma, as well as bleeding within the abdominal wall have also been described. A subcapsular\u00a0hematoma\u00a0usually occurs when\u00a0performing RFA on\u00a0tumors located immediately below the liver's surface. This location is prone to this complication because the electrode tract cannot be cauterized on withdrawal due to its shallow depth. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hemorrhage. Bleeding within the liver capsule, known as a subcapsular hematoma, as well as bleeding within the abdominal wall have also been described. A subcapsular\u00a0hematoma\u00a0usually occurs when\u00a0performing RFA on\u00a0tumors located immediately below the liver's surface. This location is prone to this complication because the electrode tract cannot be cauterized on withdrawal due to its shallow depth. [37]"}
{"id": "article-26933_44", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Infection", "content": "Infection\u00a0is another relatively common\u00a0entity\u00a0encountered following an RFA procedure.\u00a0The category of RFA-associated infection is broad and includes abscess and wound infection. Post-RFA abscess is an insidious complication as it can appear long after the procedure. Risk factors for the development of post-RFA abscess include anomalous biliary anatomy\u00a0(Whipple or other forms of bilio-enteric anastomosis, prior papillotomy, etc.), which\u00a0render a patient susceptible\u00a0to ascending infection.\u00a0The most common symptoms of liver abscess are fever and abdominal pain. The signs and symptoms\u00a0of hepatic abscess typically occur in less than four weeks\u00a0following RFA but can\u00a0occur as far out as 60+ days.\u00a0While a fever immediately following RFA is common\u00a0and may be related to post-ablation syndrome, a fever that persists beyond two weeks should raise suspicion for an infectious etiology.\u00a0CT scan is confirmatory. Enterococcus , Escherichia, Bacteroides, Clostridium, and Klebsiella are the most common culprits.\u00a0Treatment requires a combination of both\u00a0antibiotic therapy and percutaneous drainage. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Infection. Infection\u00a0is another relatively common\u00a0entity\u00a0encountered following an RFA procedure.\u00a0The category of RFA-associated infection is broad and includes abscess and wound infection. Post-RFA abscess is an insidious complication as it can appear long after the procedure. Risk factors for the development of post-RFA abscess include anomalous biliary anatomy\u00a0(Whipple or other forms of bilio-enteric anastomosis, prior papillotomy, etc.), which\u00a0render a patient susceptible\u00a0to ascending infection.\u00a0The most common symptoms of liver abscess are fever and abdominal pain. The signs and symptoms\u00a0of hepatic abscess typically occur in less than four weeks\u00a0following RFA but can\u00a0occur as far out as 60+ days.\u00a0While a fever immediately following RFA is common\u00a0and may be related to post-ablation syndrome, a fever that persists beyond two weeks should raise suspicion for an infectious etiology.\u00a0CT scan is confirmatory. Enterococcus , Escherichia, Bacteroides, Clostridium, and Klebsiella are the most common culprits.\u00a0Treatment requires a combination of both\u00a0antibiotic therapy and percutaneous drainage. [37]"}
{"id": "article-26933_45", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Biliary Tract Damage", "content": "Damage to the biliary tract\u00a0encompasses direct ductal injury, stricture, biloma, and, far more rarely, bilioperitoneum and bilio-pleural fistula/bilious effusion. Biliary tract damage is the result of\u00a0direct\u00a0thermal injury from RFA as well as electrode-mediated mechanical injury.\u00a0These types of complications are most common in tumors located in the hepatic hila or in lesions\u00a0within 1 cm of major bile ducts. Such close proximity to these ducts impedes the safe procurement of the necessary margin of normal hepatic parenchyma surrounding the tumor. Of the aforementioned complications, biliary strictures are the most common.\u00a0A stricture of the biliary tract can\u00a0develop anywhere from one week to several months following RFA. The diagnosis is\u00a0typically made via CT or MRCP.\u00a0ERCP\u00a0represents both a diagnostic and therapeutic modality as\u00a0it may be used\u00a0for stent placement if the stricture is located in the hilum or common bile duct. Strictures\u00a0at the level of the ampulla of Vater are\u00a0treated via\u00a0endoscopic sphincterotomy. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Biliary Tract Damage. Damage to the biliary tract\u00a0encompasses direct ductal injury, stricture, biloma, and, far more rarely, bilioperitoneum and bilio-pleural fistula/bilious effusion. Biliary tract damage is the result of\u00a0direct\u00a0thermal injury from RFA as well as electrode-mediated mechanical injury.\u00a0These types of complications are most common in tumors located in the hepatic hila or in lesions\u00a0within 1 cm of major bile ducts. Such close proximity to these ducts impedes the safe procurement of the necessary margin of normal hepatic parenchyma surrounding the tumor. Of the aforementioned complications, biliary strictures are the most common.\u00a0A stricture of the biliary tract can\u00a0develop anywhere from one week to several months following RFA. The diagnosis is\u00a0typically made via CT or MRCP.\u00a0ERCP\u00a0represents both a diagnostic and therapeutic modality as\u00a0it may be used\u00a0for stent placement if the stricture is located in the hilum or common bile duct. Strictures\u00a0at the level of the ampulla of Vater are\u00a0treated via\u00a0endoscopic sphincterotomy. [37]"}
{"id": "article-26933_46", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Biliary Tract Damage", "content": "Biloma, an organized\u00a0collection of bile located outside of the biliary tree, results from damage to the biliary tract and subsequent leakage of bile.\u00a0Bile duct injury resulting in biloma may be mediated\u00a0by direct mechanical injury from the electrode probe as well as thermal damage. When seen with CT, it\u00a0appears\u00a0as a\u00a0well-circumscribed fluid collection\u00a0generally in close proximity to the ablation zone. The majority of bilomas\u00a0occur within the first four months following RFA but\u00a0have been reported as far out as\u00a017 months in the literature. Most patients experience no symptoms, and in about 50% of cases, the biloma regresses without intervention. Percutaneous drainage is required for resolution in the other half of patients. Focused imaging evaluation of the sphincter of Oddi\u00a0is important\u00a0to exclude increased biliary pressure related to RFA-induced biliary stenosis as an occult\u00a0etiology\u00a0for biloma formation. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Biliary Tract Damage. Biloma, an organized\u00a0collection of bile located outside of the biliary tree, results from damage to the biliary tract and subsequent leakage of bile.\u00a0Bile duct injury resulting in biloma may be mediated\u00a0by direct mechanical injury from the electrode probe as well as thermal damage. When seen with CT, it\u00a0appears\u00a0as a\u00a0well-circumscribed fluid collection\u00a0generally in close proximity to the ablation zone. The majority of bilomas\u00a0occur within the first four months following RFA but\u00a0have been reported as far out as\u00a017 months in the literature. Most patients experience no symptoms, and in about 50% of cases, the biloma regresses without intervention. Percutaneous drainage is required for resolution in the other half of patients. Focused imaging evaluation of the sphincter of Oddi\u00a0is important\u00a0to exclude increased biliary pressure related to RFA-induced biliary stenosis as an occult\u00a0etiology\u00a0for biloma formation. [37]"}
{"id": "article-26933_47", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Liver Failure", "content": "Liver failure is one of the most severe RFA-related complications as it can be fatal in patients with hepatic cirrhosis whose liver function\u00a0is typically already impaired. Prior partial hepatectomy is another risk factor as these patients lack the parenchymal volume to mount an effective compensatory\u00a0functional response. The acute (or acute on chronic) failure is\u00a0thought to occur due to\u00a0vascular injury,\u00a0which results in hepatic infarction.\u00a0Preprocedural imaging with careful electrode entry point planning\u00a0is essential to avoid this complication. Another suggested cause of post-RFA liver failure is overly extensive ablation in the setting of cirrhosis. The destruction of impaired but functioning parenchyma\u00a0may push the patient into overt liver failure. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Liver Failure. Liver failure is one of the most severe RFA-related complications as it can be fatal in patients with hepatic cirrhosis whose liver function\u00a0is typically already impaired. Prior partial hepatectomy is another risk factor as these patients lack the parenchymal volume to mount an effective compensatory\u00a0functional response. The acute (or acute on chronic) failure is\u00a0thought to occur due to\u00a0vascular injury,\u00a0which results in hepatic infarction.\u00a0Preprocedural imaging with careful electrode entry point planning\u00a0is essential to avoid this complication. Another suggested cause of post-RFA liver failure is overly extensive ablation in the setting of cirrhosis. The destruction of impaired but functioning parenchyma\u00a0may push the patient into overt liver failure. [37]"}
{"id": "article-26933_48", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Pulmonary Complications", "content": "Pneumothoraces, pleural effusions, and cases of pneumonia are examples of RFA-related pulmonary complications. As one might expect, pneumothorax is commonly associated with the treatment of\u00a0hepatic lesions in\u00a0close proximity to the\u00a0diaphragm, for which an intercostal approach is necessary.\u00a0Satisfactory electrode probe\u00a0positioning\u00a0in a\u00a0safe window predetermined by preprocedural imaging reduces the risk.\u00a0CT evaluation\u00a0is required\u00a0with dyspnea or chest pain are experienced by the patient following RFA. If present, admission to the hospital and vital sign monitoring may be warranted. For large,\u00a0quickly enlarging, or symptomatic pneumothoraces, chest tube placement with serial chest x-rays is\u00a0usually necessary. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Pulmonary Complications. Pneumothoraces, pleural effusions, and cases of pneumonia are examples of RFA-related pulmonary complications. As one might expect, pneumothorax is commonly associated with the treatment of\u00a0hepatic lesions in\u00a0close proximity to the\u00a0diaphragm, for which an intercostal approach is necessary.\u00a0Satisfactory electrode probe\u00a0positioning\u00a0in a\u00a0safe window predetermined by preprocedural imaging reduces the risk.\u00a0CT evaluation\u00a0is required\u00a0with dyspnea or chest pain are experienced by the patient following RFA. If present, admission to the hospital and vital sign monitoring may be warranted. For large,\u00a0quickly enlarging, or symptomatic pneumothoraces, chest tube placement with serial chest x-rays is\u00a0usually necessary. [37]"}
{"id": "article-26933_49", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Cutaneous Thermal Injury", "content": "Skin burns are a known complication related to RFA. They typically occur at two sites: the point of\u00a0electrode probe\u00a0entry and along the grounding pads. Life-threatening\u00a0scorch injuries\u00a0are rare but have been reported in the literature. Manufacturer increases in the number and size of the grounding pads have, in recent years, greatly reduced the occurrence of this complication because larger and more numerous pads more effectively disperse the high volume of energy generated by the electrical current.\u00a0Additionally,\u00a0satisfactory pad placement\u00a0with\u00a0adequate skin contact and equidistant positioning from the electrode probe is also essential in the prevention of skin burns. Asymmetric distribution of electrical current may occur when the pads are not appropriately positioned, which\u00a0prevents temperature uniformity and, thus, higher temperatures in the pads closer to the probe, resulting in cutaneous damage. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Cutaneous Thermal Injury. Skin burns are a known complication related to RFA. They typically occur at two sites: the point of\u00a0electrode probe\u00a0entry and along the grounding pads. Life-threatening\u00a0scorch injuries\u00a0are rare but have been reported in the literature. Manufacturer increases in the number and size of the grounding pads have, in recent years, greatly reduced the occurrence of this complication because larger and more numerous pads more effectively disperse the high volume of energy generated by the electrical current.\u00a0Additionally,\u00a0satisfactory pad placement\u00a0with\u00a0adequate skin contact and equidistant positioning from the electrode probe is also essential in the prevention of skin burns. Asymmetric distribution of electrical current may occur when the pads are not appropriately positioned, which\u00a0prevents temperature uniformity and, thus, higher temperatures in the pads closer to the probe, resulting in cutaneous damage. [37]"}
{"id": "article-26933_50", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Tract Seeding", "content": "The seeding of the electrode probe tract is a well-described phenomenon associated with percutaneous RFA. Transfer of tumor cells\u00a0from the\u00a0lesion to the probe tract occurs when viable cancer cells adhere to the probe on withdrawal following the procedure. Choosing the entry point with the least amount of hepatic parenchyma between the skin and the lesion, as well as decreasing the number of probe punctures, helps\u00a0to decrease the frequency of this complication.\u00a0Optimum, first-attempt\u00a0probe positioning should be the goal. Furthermore, cauterization of the probe tract has also effectively lowered the rate of occurrence. Additional\u00a0factors that place a patient at risk for developing tract seeding include cancer, which is poorly differentiated, subcapsular tumor location (a contraindication to tract cauterization), and multiple\u00a0electrode probe insertions. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Tract Seeding. The seeding of the electrode probe tract is a well-described phenomenon associated with percutaneous RFA. Transfer of tumor cells\u00a0from the\u00a0lesion to the probe tract occurs when viable cancer cells adhere to the probe on withdrawal following the procedure. Choosing the entry point with the least amount of hepatic parenchyma between the skin and the lesion, as well as decreasing the number of probe punctures, helps\u00a0to decrease the frequency of this complication.\u00a0Optimum, first-attempt\u00a0probe positioning should be the goal. Furthermore, cauterization of the probe tract has also effectively lowered the rate of occurrence. Additional\u00a0factors that place a patient at risk for developing tract seeding include cancer, which is poorly differentiated, subcapsular tumor location (a contraindication to tract cauterization), and multiple\u00a0electrode probe insertions. [37]"}
{"id": "article-26933_51", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hepatic Vascular Damage", "content": "With hemorrhage having been described above, remaining RFA-related vascular complications include thrombosis of the portal vein and/or hepatic vein\u00a0as well as\u00a0pseudoaneurysm formation. Coagulation with resultant thrombosis\u00a0of vasculature in excess of\u00a03 mm is rare when normal anatomical blood flow is present. Because of extensive collateralization of both arterial and venous blood supply to the liver, most thromboses are asymptomatic such that no intervention is\u00a0necessary. Blood clots are\u00a0the result of\u00a0thermal endothelial damage, which leads to\u00a0the aggregation of platelets and subsequent activation of the coagulation cascade.\u00a0Care should be taken to\u00a0avoid this complication, particularly in patients with cirrhosis, because it could push a patient with preexisting liver dysfunction in fulminant liver failure. In this setting, portal vein thrombosis represents a\u00a0potentially\u00a0life-threatening complication. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hepatic Vascular Damage. With hemorrhage having been described above, remaining RFA-related vascular complications include thrombosis of the portal vein and/or hepatic vein\u00a0as well as\u00a0pseudoaneurysm formation. Coagulation with resultant thrombosis\u00a0of vasculature in excess of\u00a03 mm is rare when normal anatomical blood flow is present. Because of extensive collateralization of both arterial and venous blood supply to the liver, most thromboses are asymptomatic such that no intervention is\u00a0necessary. Blood clots are\u00a0the result of\u00a0thermal endothelial damage, which leads to\u00a0the aggregation of platelets and subsequent activation of the coagulation cascade.\u00a0Care should be taken to\u00a0avoid this complication, particularly in patients with cirrhosis, because it could push a patient with preexisting liver dysfunction in fulminant liver failure. In this setting, portal vein thrombosis represents a\u00a0potentially\u00a0life-threatening complication. [37]"}
{"id": "article-26933_52", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hepatic Vascular Damage", "content": "RFA-induced thermal damage to the hepatic artery may result in small-scale arterioportal shunting. The majority of these small defects will heal spontaneously.\u00a0In the absence of self resolution, these shunts can be corrected with\u00a0endovascular intervention. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Hepatic Vascular Damage. RFA-induced thermal damage to the hepatic artery may result in small-scale arterioportal shunting. The majority of these small defects will heal spontaneously.\u00a0In the absence of self resolution, these shunts can be corrected with\u00a0endovascular intervention. [37]"}
{"id": "article-26933_53", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Visceral Damage", "content": "While extremely rare, RFA-related damage to the abdominal organs has been reported in the literature.\u00a0Peripherally located and subcapsular tumors (less than 1 cm from nearby organs)\u00a0impart the\u00a0highest risk.\u00a0Additional factors\u00a0that increase the risk of abdominal organ injury include\u00a0prior abdominal surgery\u00a0as well as chronic cholecystitis (which is known to cause adhesions between the liver and bowel).\u00a0In these cases,\u00a0an open or laparoscopic RFA approach is preferred to confirm these organs are physically separated. Hydrodissection (also known as artificial ascites) may help mitigate the risk. This technique involves the introduction of 5% dextrose or normal saline to the peritoneal cavity\u00a0in order to increase the\u00a0distance between the liver and\u00a0abdominal viscera. [37]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Complications -- Visceral Damage. While extremely rare, RFA-related damage to the abdominal organs has been reported in the literature.\u00a0Peripherally located and subcapsular tumors (less than 1 cm from nearby organs)\u00a0impart the\u00a0highest risk.\u00a0Additional factors\u00a0that increase the risk of abdominal organ injury include\u00a0prior abdominal surgery\u00a0as well as chronic cholecystitis (which is known to cause adhesions between the liver and bowel).\u00a0In these cases,\u00a0an open or laparoscopic RFA approach is preferred to confirm these organs are physically separated. Hydrodissection (also known as artificial ascites) may help mitigate the risk. This technique involves the introduction of 5% dextrose or normal saline to the peritoneal cavity\u00a0in order to increase the\u00a0distance between the liver and\u00a0abdominal viscera. [37]"}
{"id": "article-26933_54", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Clinical Significance", "content": "In addition to percutaneous radiofrequency ablation, several additional ablative techniques such as microwave and cryotherapy have emerged as effective alternatives. According to the literature, the overall survival and local recurrence rates, as well as complications and mortality rates in liver metastases patients treated with radiofrequency ablation (vs. microwave ablation), are not statistically different in terms of both survival time from diagnosis and survival time from ablation. [38]", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Clinical Significance. In addition to percutaneous radiofrequency ablation, several additional ablative techniques such as microwave and cryotherapy have emerged as effective alternatives. According to the literature, the overall survival and local recurrence rates, as well as complications and mortality rates in liver metastases patients treated with radiofrequency ablation (vs. microwave ablation), are not statistically different in terms of both survival time from diagnosis and survival time from ablation. [38]"}
{"id": "article-26933_55", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Enhancing Healthcare Team Outcomes", "content": "Percutaneous local treatment is an attractive new tool for patients with cancer, especially for disease in the liver. There is no effective treatment currently available for the vast majority of patients with metastatic liver disease. Most primary liver tumors are unresectable at diagnosis. In such cases, local treatment preserves uninvolved liver tissue and has potentially fewer systemic complications. It has less morbidity and mortality in comparison to major liver surgery as well. However, it is not a replacement for surgery.", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Enhancing Healthcare Team Outcomes. Percutaneous local treatment is an attractive new tool for patients with cancer, especially for disease in the liver. There is no effective treatment currently available for the vast majority of patients with metastatic liver disease. Most primary liver tumors are unresectable at diagnosis. In such cases, local treatment preserves uninvolved liver tissue and has potentially fewer systemic complications. It has less morbidity and mortality in comparison to major liver surgery as well. However, it is not a replacement for surgery."}
{"id": "article-26933_56", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Enhancing Healthcare Team Outcomes", "content": "An interprofessional team approach is vital to the care of the oncology patient. Interventional radiologists work closely with\u00a0surgeons, oncologists, radiation oncologists, and other specialists with the goal of providing the best possible outcome for these patients.", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Enhancing Healthcare Team Outcomes. An interprofessional team approach is vital to the care of the oncology patient. Interventional radiologists work closely with\u00a0surgeons, oncologists, radiation oncologists, and other specialists with the goal of providing the best possible outcome for these patients."}
{"id": "article-26933_57", "title": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Percutaneous Radiofrequency Ablation of Liver Tumors -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}